Ubs Asset Management Americas Inc Glaukos Corp Transaction History

Ubs Asset Management Americas Inc

  • $446 Billion
  • Q3 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Glaukos Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 145,621 shares of GKOS stock, worth $13.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145,621
Previous 279,393 47.88%
Holding current value
$13.1 Million
Previous $28.9 Million 58.85%
% of portfolio
0.0%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$79.92 - $106.55 $10.7 Million - $14.3 Million
-133,772 Reduced 47.88%
145,621 $11.9 Million
Q2 2025

Aug 14, 2025
BUY
$82.27 - $103.29 $4.06 Million - $5.1 Million
49,399 Added 21.48%
279,393 $28.9 Million
Q1 2025

May 19, 2025
BUY
$96.6 - $161.22 $6.54 Million - $10.9 Million
67,668 Added 41.69%
229,994 $22.6 Million
Q4 2024

Feb 14, 2025
BUY
$126.42 - $152.67 $3.53 Million - $4.26 Million
27,889 Added 20.75%
162,326 $24.3 Million
Q3 2024

Nov 14, 2024
SELL
$113.62 - $135.39 $293,366 - $349,576
-2,582 Reduced 1.88%
134,437 $17.5 Million
Q2 2024

Aug 13, 2024
BUY
$89.48 - $118.35 $6.28 Million - $8.3 Million
70,155 Added 104.92%
137,019 $16.2 Million
Q1 2024

May 15, 2024
BUY
$76.4 - $96.33 $547,176 - $689,915
7,162 Added 12.0%
66,864 $6.3 Million
Q4 2023

Feb 14, 2024
BUY
$59.53 - $85.11 $157,456 - $225,115
2,645 Added 4.64%
59,702 $4.75 Million
Q3 2023

Nov 13, 2023
BUY
$69.23 - $79.09 $416,279 - $475,568
6,013 Added 11.78%
57,057 $4.29 Million
Q1 2023

May 15, 2023
SELL
$43.88 - $52.48 $16,455 - $19,680
-375 Reduced 0.73%
51,044 $2.56 Million
Q4 2022

Feb 14, 2023
BUY
$40.82 - $57.75 $27,308 - $38,634
669 Added 1.32%
51,419 $2.25 Million
Q3 2022

Nov 14, 2022
SELL
$46.84 - $58.49 $498,846 - $622,918
-10,650 Reduced 17.35%
50,750 $2.7 Million
Q2 2022

Aug 12, 2022
BUY
$34.86 - $63.77 $10,423 - $19,067
299 Added 0.49%
61,400 $2.79 Million
Q1 2022

May 16, 2022
BUY
$44.33 - $57.82 $536,791 - $700,142
12,109 Added 24.72%
61,101 $3.53 Million
Q4 2021

Feb 14, 2022
BUY
$40.27 - $56.99 $13,128 - $18,578
326 Added 0.67%
48,992 $2.18 Million
Q3 2021

Nov 15, 2021
BUY
$47.43 - $84.23 $48,947 - $86,925
1,032 Added 2.17%
48,666 $2.34 Million
Q2 2021

Aug 16, 2021
BUY
$73.06 - $97.7 $268,787 - $359,438
3,679 Added 8.37%
47,634 $4.04 Million
Q1 2021

May 14, 2021
SELL
$70.43 - $97.42 $1,126 - $1,558
-16 Reduced 0.04%
43,955 $3.69 Million
Q4 2020

Mar 01, 2021
BUY
$48.9 - $75.26 $65,574 - $100,923
1,341 Added 3.15%
43,971 $3.31 Million
Q3 2020

Nov 13, 2020
SELL
$37.23 - $50.97 $121,891 - $166,875
-3,274 Reduced 7.13%
42,630 $2.11 Million
Q2 2020

Aug 14, 2020
SELL
$28.78 - $46.83 $13,267 - $21,588
-461 Reduced 0.99%
45,904 $1.76 Million
Q1 2020

May 15, 2020
BUY
$25.53 - $70.14 $126,143 - $346,561
4,941 Added 11.93%
46,365 $1.43 Million
Q4 2019

Feb 14, 2020
BUY
$54.18 - $65.64 $95,898 - $116,182
1,770 Added 4.46%
41,424 $2.26 Million
Q3 2019

Nov 14, 2019
BUY
$58.58 - $83.91 $532,902 - $763,329
9,097 Added 29.77%
39,654 $2.48 Million
Q2 2019

Aug 15, 2019
BUY
$63.59 - $78.71 $237,635 - $294,139
3,737 Added 13.93%
30,557 $0
Q1 2019

May 14, 2019
BUY
$50.75 - $80.54 $184,882 - $293,407
3,643 Added 15.72%
26,820 $0
Q4 2018

Feb 13, 2019
BUY
$52.18 - $67.93 $295,234 - $384,347
5,658 Added 32.3%
23,177 $1.3 Million
Q3 2018

Nov 14, 2018
BUY
$38.13 - $68.37 $168,496 - $302,127
4,419 Added 33.73%
17,519 $0
Q2 2018

Aug 14, 2018
BUY
$27.62 - $44.51 $179,530 - $289,315
6,500 Added 98.48%
13,100 $0
Q1 2018

May 14, 2018
BUY
$26.05 - $34.5 $171,930 - $227,700
6,600 New
6,600 $0
Q4 2017

Feb 09, 2018
SELL
$24.5 - $36.01 $161,700 - $237,666
-6,600 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$31.26 - $42.03 $206,316 - $277,398
6,600
6,600 $0

Others Institutions Holding GKOS

# of Institutions
351
Shares Held
55.3M
Call Options Held
163K
Put Options Held
458K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.29B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email